Deinove announced on Wednesday that the Montpellier Commercial Court had handed down a judgment converting the company's receivership proceedings, initiated last November, into a judicial liquidation.

As no takeover offer had been received by the January 9 deadline for submitting bids, Deinove had asked Euronext to suspend the listing of its shares on January 11.

The French biotech company, a pioneer in bacterial biodiversity and antimicrobial resistance, indicates that its listing will remain suspended until the end of the delisting procedure, which is expected to take place shortly.

In the event that the judicial liquidation does not result in the distribution of a bonus to shareholders, Deinove will inform its shareholders that their shares are worthless.

Copyright (c) 2023 CercleFinance.com. All rights reserved.